Question 692

In DTC would non-medical devices (i.e. Breezhaler/Respimat/Ellipta) be associated with their drugs immediately? As such be limited to the name, price and quantity in terms of messaging or would there be leeway to talk about device features in a comparative standpoint or would that be against the code?
Please see Ask PAAB question 500 (search: Device). As it is our understanding that Breezhaler/Respimat/Ellipta are not Class I, II, III or IV medical devices, and promotion of these devices would be promotion of the products and therefore unacceptable

Resources

Do you have questions? We have answers!